Breaking News

5-Day Course of Remdesivir (Veklury) Found Effective

October 5, 2020 • 5:12 pm CDT
(Precision Vaccinations)

A Living Systematic Review for an American College of Physicians Practice Points published on October 5, 2020, concluded 'In hospitalized adults with COVID-19, remdesivir (Velury) probably improves recovery and reduces serious adverse events and may reduce mortality and time to clinical improvement.'

'For adults not receiving mechanical ventilation or extracorporeal membrane oxygenation, a 5-day course of remdesivir (Veklury) may provide similar benefits to and fewer harms than a 10-day course.'